1. Scientific Rationale for Combination of a Calcium Channel Antagonist and an HMG-CoA Reductase Inhibitor

   • R. Preston Mason

   Current Opinion 17 September 2012 Pages: 885 - 900

   

2. Novel Thrombopoietic Agents

   • Roberto Stasi
   • Maria L. Evangelista
   • Sergio Amadori

   Leading Article 17 September 2012 Pages: 901 - 912

   

3. Management of Breakthrough Pain in Patients with Cancer

   • Leeroy William
   • Rod MacLeod

   Therapy in Practice 17 September 2012 Pages: 913 - 924

   

4. Guide to the Use of Proton Pump Inhibitors in Adult Patients

   • Vandana Boparai
   • Jaishree Rajagopalan
   • George Triadafilopoulos

   Review Article 17 September 2012 Pages: 925 - 947

   

5. Capecitabine, Alone and in Combination, in the Management of Patients with Colorectal Cancer

   • Pasquale Comella
   • Rossana Casaretti
   • Luca Franco

   Review Article 17 September 2012 Pages: 949 - 961

   

6. Renal Disease in Patients with HIV Infection

   • Derek M. Fine
   • Mark A. Perazella
   • Mohamed G. Atta

   Review Article 17 September 2012 Pages: 963 - 980

   

7. Mosapride

   • Monique P. Curran
   • Dean M. Robinson

   Adis Drug Profile 17 September 2012 Pages: 981 - 991

   

8. Posaconazole

   • James E. Frampton
   • Lesley J. Scott

   Adis Drug Evaluation 17 September 2012 Pages: 993 - 1016

   

9. Drugs in the Newspapers

   • Giampaolo Velo
   • Riccardo Renzi
   • Roberto Satolli

   Correspondence 17 September 2012 Pages: 1017 - 1018